Browse > Article
http://dx.doi.org/10.3904/kjim.2011.26.3.320

Effects of Lowering Dialysate Calcium Concentrations on Arterial Stiffness in Patients Undergoing Hemodialysis  

Kim, Jwa-Kyung (Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine)
Moon, Sung-Jin (Department of Internal Medicine, Kwandong University College of Medicine)
Park, Hyeong-Cheon (Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine)
Lee, Jae-Sung (Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine)
Sim, Soung-Rok (Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine)
Bae, Sung-Chang (Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine)
Ha, Sung-Kyu (Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine)
Publication Information
The Korean journal of internal medicine / v.26, no.3, 2011 , pp. 320-327 More about this Journal
Abstract
Background/Aims: We assessed changes in hemodynamic and arterial stiffness parameters following reductions of dialysate calcium concentrations in patients undergoing hemodialysis. Methods: In this prospective study, 20 patients on maintenance hemodialysis (10 females, 10 males) with dialysate calcium concentrations of 1.75 mmol/L were enrolled. At the start of the study, the dialysate calcium level was lowered to 1.50 mmol/L. Serial changes in biochemical, hemodynamic, and arterial stiffness parameters, including pulse wave velocity (PWV) and augmentation index (AIx), were assessed every 2 months for 6 months. We also examined changes in the calcification-inhibitory protein, serum fetuin-A. Results: During the 6-month study period, serum total calcium and ionized calcium decreased consistently (9.5 ${\pm}$ 1.0 to 9.0 ${\pm}$ 0.7, p = 0.002 vs. 1.3 ${\pm}$ 0.1 to 1.1 ${\pm}$ 0.1, p = 0.035). Although no apparent changes in blood pressure were observed, heart-femoral PWW (hf-PWV) and AIx showed significant improvement (p = 0.012, 0.043, respectively). Repeated-measures ANOVA indicated a significant effect of lowering dialysate calcium on hf-PWV (F = 4.58, p = 0.004) and AIx (F = 2.55, p = 0.049). Accompanying the change in serum calcium, serum fetuin-A levels significantly increased (95.8 ${\pm}$ 45.8 pmol/mL at baseline to 124.9 ${\pm}$ 82.2 pmol/mL at 6 months, p = 0.043). Conclusions: Lowering dialysate calcium concentration significantly improved arterial stiffness parameters, which may have been associated with upregulation of serum fetuin-A.
Keywords
Arterial stiffness; Calcium; Dialysis solutions; Fetuin A; Hemodialysis;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
Times Cited By SCOPUS : 0
연도 인용수 순위
1 Demirci MS, Ozkahya M, Asci G, et al. The influence of dialysate calcium on progression of arterial stiffness in peritoneal dialysis patients. Perit Dial Int 2009;29 Suppl 2:S15-S17.
2 Essalihi R, Zandvliet ML, Moreau S, et al. Distinct effects of amlodipine treatment on vascular elastocalcinosis and stiffness in a rat model of isolated systolic hypertension. J Hypertens 2007;25:1879-1886.   DOI   ScienceOn
3 Speer G, Fekete BC, El Hadj Othmane T, et al. Serum osteoprotegerin level, carotid-femoral pulse wave velocity and cardiovascular survival in haemodialysis patients. Nephrol Dial Transplant 2008;23:3256-3262.   DOI   ScienceOn
4 Nakamura U, Iwase M, Nohara S, Kanai H, Ichikawa K, Iida M. Usefulness of brachial-ankle pulse wave velocity measurement: correlation with abdominal aortic calcification. Hypertens Res 2003;26:163-167.   DOI   ScienceOn
5 Giachelli CM. Vascular calcification mechanisms. J Am Soc Nephrol 2004;15:2959-2964.   DOI   ScienceOn
6 Yoo SJ, Oh DJ, Yu SH. The effects of low calcium dialysate on arterial compliance and vasoactive substances in patients with hemodialysis. Korean J Intern Med 2004;19:27-32.   DOI   ScienceOn
7 Gotch F, Levin NW, Kotanko P. Calcium balance in dialysis is best managed by adjusting dialysate calcium guided by kinetic modeling of the interrelationship between calcium intake, dose of vitamin D analogues and the dialysate calcium concentration. Blood Purif 2010;29:163-176.   DOI   ScienceOn
8 Kyriazis J, Katsipi I, Stylianou K, Jenakis N, Karida A, Daphnis E. Arterial stiffness alterations during hemodialysis: the role of dialysate calcium. Nephron Clin Pract 2007;106:c34-c42.   DOI   ScienceOn
9 Lezaic V, Pejanovic S, Kostic S, et al. Effects of lowering dialysate calcium concentration on mineral metabolism and parathyroid hormone secretion: a multicentric study. Ther Apher Dial 2007;11:121-130.   DOI   ScienceOn
10 Argiles A, Kerr PG, Canaud B, Flavier JL, Mion C. Calcium kinetics and the long-term effects of lowering dialysate calcium concentration. Kidney Int 1993;43:630-640.   DOI   ScienceOn
11 Sage AP, Tintut Y, Demer LL. Regulatory mechanisms in vascular calcification. Nat Rev Cardiol 2010;7:528-536.   DOI   ScienceOn
12 Lebreton JP, Joisel F, Raoult JP, Lannuzel B, Rogez JP, Humbert G. Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant. J Clin Invest 1979;64:1118-1129.   DOI
13 Shroff RC, Shah V, Hiorns MP, et al. The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis. Nephrol Dial Transplant 2008;23:3263-3271.   DOI   ScienceOn
14 Stenvinkel P, Wang K, Qureshi AR, et al. Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin. Kidney Int 2005;67:2383-2392.   DOI   ScienceOn
15 Mori K, Emoto M, Araki T, et al. Association of serum fetuin-A with carotid arterial stiffness. Clin Endocrinol (Oxf) 2007;66:246-250.   DOI   ScienceOn
16 Ketteler M, Bongartz P, Westenfeld R, et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003;361:827-833.   DOI   ScienceOn
17 Kundhal K, Lok CE. Clinical epidemiology of cardiovascular disease in chronic kidney disease. Nephron Clin Pract 2005;101:c47-c52.   DOI   ScienceOn
18 Sigrist MK, Levin A, Er L, McIntyre CW. Elevated osteoprotegerin is associated with all-cause mortality in CKD stage 4 and 5 patients in addition to vascular calcification. Nephrol Dial Transplant 2009;24:3157-3162.   DOI   ScienceOn
19 Goldsmith D, Ritz E, Covic A. Vascular calcification: a stiff challenge for the nephrologist: does preventing bone disease cause arterial disease? Kidney Int 2004;66:1315-1333.   DOI   ScienceOn
20 LeBeouf A, Mac-Way F, Utescu MS, et al. Effects of acute variation of dialysate calcium concentrations on arterial stif fness and aor tic pressure waveform. Nephrol Dial Transplant 2009;24:3788-3794.   DOI   ScienceOn
21 Shroff RC, Shanahan CM. The vascular biology of calcification. Semin Dial 2007;20:103-109.   DOI   ScienceOn
22 Adragao T, Frazao JM. Cardiovascular risk in dialysis patients: an X-ray vision on vascular calcifications. Kidney Int 2008;74:1505-1507.   DOI   ScienceOn
23 London GM, Marchais SJ, Guerin AP, Metivier F, Adda H. Arterial structure and function in end-stage renal disease. Nephrol Dial Transplant 2002;17:1713-1724.   DOI   ScienceOn
24 Marchais S, Guerin A, Safar M, London G. Arterial compliance in uraemia. J Hypertens Suppl 1989;7:S84-S85.   DOI
25 Ogawa O, Onuma T, Kubo S, Mitsuhashi N, Muramatsu C, Kawamori R. Brachial-ankle pulse wave velocity and symptomatic cerebral infarction in patients with type 2 diabetes: a cross-sectional study. Cardiovasc Diabetol 2003;2:10.   DOI   ScienceOn
26 Hatsuda S, Shoji T, Shinohara K, et al. Regional arterial stiffness associated with ischemic heart disease in type 2 diabetes mellitus. J Atheroscler Thromb 2006;13:114-121.   DOI   ScienceOn
27 Cheng IK, Lu HB, Chan CY, et al. The requirement of low calcium dialysate in patients on continuous ambulatory peritoneal dialysis receiving calcium carbonate as a phosphate binder. Clin Nephrol 1993;40:100-105.